Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease.
<h4>Background</h4>The proteases (secretases) that cleave amyloid-beta (Abeta) peptide from the amyloid precursor protein (APP) have been the focus of considerable investigation in the development of treatments for Alzheimer disease. The prediction has been that reducing Abeta production...
Saved in:
| Main Authors: | Joanna L Jankowsky, Hilda H Slunt, Victoria Gonzales, Alena V Savonenko, Jason C Wen, Nancy A Jenkins, Neal G Copeland, Linda H Younkin, Henry A Lester, Steven G Younkin, David R Borchelt |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2005-12-01
|
| Series: | PLoS Medicine |
| Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.0020355&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concordant association of insulin degrading enzyme gene (IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease.
by: Minerva M Carrasquillo, et al.
Published: (2010-01-01) -
Specific Binding of Alzheimer’s Abeta Peptide Fibrils to Single Walled Carbon Nanotubes
by: Steingrimur Stefansson, et al.
Published: (2012-10-01) -
Sequestration of the Abeta peptide prevents toxicity and promotes degradation in vivo.
by: Leila M Luheshi, et al.
Published: (2010-03-01) -
Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease.
by: Oyinkan Sofola, et al.
Published: (2010-09-01) -
Physiological mouse brain Abeta levels are not related to the phosphorylation state of threonine-668 of Alzheimer's APP.
by: Yoshitake Sano, et al.
Published: (2006-12-01)